Literature DB >> 28368480

Genetic and Histopathologic Intertumor Heterogeneity in Primary Aldosteronism.

Kei Omata1,2,3, Yuto Yamazaki4, Yasuhiro Nakamura4,5, Sharath K Anand1, Justine A Barletta6, Hironobu Sasano4, William E Rainey7,8, Scott A Tomlins1,9,10,11, Anand Vaidya12.   

Abstract

Context: Whether primary aldosteronism (PA) is the consequence of a monoclonal or multiclonal process is unclear. Case Description: A 48-year-old man with severe bilateral PA refractory to medical therapy underwent unilateral adrenalectomy of the dominant adrenal. Although computed tomography showed three left-sided cortical nodules, postsurgical histopathology and genetic analysis revealed five different adrenocortical adenomas. Two zona fasciculata (ZF)-like aldosterone-producing adenomas (APAs) each harbored distinct known somatic KCNJ5 mutations (L168R and T158A). A zona glomerulosa-like APA harbored a known CACNA1D G403R somatic mutation, whereas a zona reticularis-like adenoma, which was grossly black in pigmentation with histologic characteristics more associated with cortisol-producing adenomas, expressed CYP11B2, CYP17, and DHEA-ST by immunohistochemistry (IHC) and harbored no known somatic mutations. The fifth adenoma was ZF-type, negative for CYP11B2 and CYP17 IHC, and harbored no known somatic mutations. Conclusions: This case highlights complex intertumor heterogeneity in histology, steroidogenesis, and somatic mutations in multiple adrenocortical adenomas arising in a single patient with PA. These findings suggest that the syndrome of PA can involve heterogeneous and multiclonal functional adrenal adenomas.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28368480      PMCID: PMC5470766          DOI: 10.1210/jc.2016-4007

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Coexistence of three distinct adrenal tumors in the same adrenal gland in a patient with primary aldosteronism and preclinical Cushing's syndrome.

Authors:  Takafumi Okura; Ken-ichi Miyoshi; Sanae Watanabe; Mie Kurata; Jun Irita; Seiko Manabe; Tomikazu Fukuoka; Jitsuo Higaki; Hironobu Sasano
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.801

2.  Black adenoma of the adrenal gland.

Authors:  Juan José Segura Fonseca; Sara Pirola
Journal:  Int J Surg Pathol       Date:  2012-02-13       Impact factor: 1.271

3.  Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.

Authors:  Fabio Luiz Fernandes-Rosa; Tracy Ann Williams; Anna Riester; Olivier Steichen; Felix Beuschlein; Sheerazed Boulkroun; Tim M Strom; Silvia Monticone; Laurence Amar; Tchao Meatchi; Franco Mantero; Maria-Verena Cicala; Marcus Quinkler; Francesco Fallo; Bruno Allolio; Giampaolo Bernini; Mauro Maccario; Gilberta Giacchetti; Xavier Jeunemaitre; Paolo Mulatero; Martin Reincke; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2014-05-27       Impact factor: 10.190

4.  Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.

Authors:  Koshiro Nishimoto; Scott A Tomlins; Rork Kuick; Andi K Cani; Thomas J Giordano; Daniel H Hovelson; Chia-Jen Liu; Aalok R Sanjanwala; Michael A Edwards; Celso E Gomez-Sanchez; Kazutaka Nanba; William E Rainey
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

5.  Molecular Heterogeneity in Aldosterone-Producing Adenomas.

Authors:  Kazutaka Nanba; Andrew X Chen; Kei Omata; Michelle Vinco; Thomas J Giordano; Tobias Else; Gary D Hammer; Scott A Tomlins; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2016-01-14       Impact factor: 5.958

6.  Colocalization of P450c17 and cytochrome b5 in androgen-synthesizing tissues of the human.

Authors:  Sejal Dharia; Audry Slane; Ming Jian; Michael Conner; Alan J Conley; C Richard Parker
Journal:  Biol Reprod       Date:  2004-02-25       Impact factor: 4.285

7.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Authors:  Elena A B Azizan; Hanne Poulsen; Petronel Tuluc; Junhua Zhou; Michael V Clausen; Andreas Lieb; Carmela Maniero; Sumedha Garg; Elena G Bochukova; Wanfeng Zhao; Lalarukh Haris Shaikh; Cheryl A Brighton; Ada E D Teo; Anthony P Davenport; Tanja Dekkers; Bas Tops; Benno Küsters; Jiri Ceral; Giles S H Yeo; Sudeshna Guha Neogi; Ian McFarlane; Nitzan Rosenfeld; Francesco Marass; James Hadfield; Wojciech Margas; Kanchan Chaggar; Miroslav Solar; Jaap Deinum; Annette C Dolphin; I Sadaf Farooqi; Joerg Striessnig; Poul Nissen; Morris J Brown
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

  7 in total
  9 in total

Review 1.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 2.  Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Paul-Emmanuel Vanderriele; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-09-25       Impact factor: 10.190

Review 3.  Primary aldosteronism - a multidimensional syndrome.

Authors:  Adina F Turcu; Jun Yang; Anand Vaidya
Journal:  Nat Rev Endocrinol       Date:  2022-08-31       Impact factor: 47.564

Review 4.  Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.

Authors:  Lucas S Santana; Augusto G Guimaraes; Madson Q Almeida
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

Review 5.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 6.  Primary Aldosteronism Diagnosis and Management: A Clinical Approach.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12       Impact factor: 4.741

Review 7.  The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor.

Authors:  Rene Baudrand; Anand Vaidya
Journal:  Int J Mol Sci       Date:  2018-02-11       Impact factor: 5.923

Review 8.  Advances in adrenal tumors 2018.

Authors:  J Crona; F Beuschlein; K Pacak; B Skogseid
Journal:  Endocr Relat Cancer       Date:  2018-07       Impact factor: 5.678

9.  Targeted RNAseq of Formalin-Fixed Paraffin-Embedded Tissue to Differentiate Among Benign and Malignant Adrenal Cortical Tumors.

Authors:  Samuel W Plaska; Chia-Jen Liu; Jung Soo Lim; Juilee Rege; Nolan R Bick; Antonio M Lerario; Gary D Hammer; Thomas J Giordano; Tobias Else; Scott A Tomlins; William E Rainey; Aaron M Udager
Journal:  Horm Metab Res       Date:  2020-08-13       Impact factor: 2.936

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.